转录组
免疫系统
免疫疗法
肺癌
生物标志物
串扰
生物
癌症免疫疗法
癌症研究
微生物群
癌症
免疫检查点
表皮生长因子受体
免疫学
医学
计算生物学
肿瘤微环境
获得性免疫系统
肿瘤科
主机响应
自然杀伤细胞
T细胞
作者
Na Wang,Lifang Ma,Yugang Huang,Xionghui Zhou,Yuan Rong,Fei Long,Wanbo Qiu,Si Wu,Yue Hu,Xin He,Jia He,Sufang Tian,Weidong Hu,Chunhui Yuan,Fubing Wang
出处
期刊:Theranostics
[Ivyspring International Publisher]
日期:2026-01-01
卷期号:16 (7): 3426-3446
被引量:3
摘要
Background: The tumor-resident microbiome plays a pivotal role in shaping the tumor immune microenvironment; however, its relationship with the host transcriptome and the response to immune checkpoint inhibitors (ICIs) remains largely uncharacterized in non-small cell lung cancer (NSCLC).This study aimed to elucidate the relationship between tissue-resident microbiota, host transcriptomic alterations, and immunotherapy response in NSCLC.Methods: Paired tumor (T) and paracancerous tissue (PT) samples from patients with NSCLC were analyzed using 2bRAD-M and bulk RNA sequencing to generate comprehensive microbiome and transcriptome profiles.The conditional mutual information algorithm was employed to systematically investigate intratumoral microbe-host interactions.Associations between key microbes and patient prognosis, ICI response, and response to epidermal growth factor receptor (EGFR)-targeted therapy were assessed across four independent local clinical cohorts.Results: Higher microbial richness, α-diversity, and β-diversity were observed in PT samples than in T samples.Specifically, PT-resident Bradyrhizobium and Prevotella were identified as key bacterial taxa significantly associated with immune cell populations, including CD8 + T cells, natural killer cells, and activated dendritic cells.Among these, PT-resident Prevotella, but not Bradyrhizobium, was independently associated with improved prognosis of patients with NSCLC and ICI response in both local clinical sets and public datasets.Furthermore, a combined diagnostic model integrating PT-resident Prevotella abundance with routine clinical blood indicators demonstrated markedly superior predictive performance for ICI response compared with the conventional biomarker PD-L1.By contrast, PT-resident Prevotella exhibited no association with treatment response in the EGFR-targeted therapy cohort.Conclusion: PT-resident Prevotella is strongly associated with the prognosis and ICI response in patients with NSCLC.Moreover, integration of PT-resident Prevotella with routine clinical blood indicators holds promise as a potential auxiliary diagnostic tool to facilitate personalized immunotherapy in NSCLC.
科研通智能强力驱动
Strongly Powered by AbleSci AI